The Effects of Low-level Laser Therapy in Extensor Tendon Injuries Between Zones 5-8 (NCT04742296) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Low-level Laser Therapy in Extensor Tendon Injuries Between Zones 5-8
Turkey (Türkiye)55 participantsStarted 2020-04-30
Plain-language summary
This study examines the rehabilitation results when low-level laser therapy is applied in zone 5-8 extensor tendon injuries. Rehabilitation results will be evaluated with both objective measurements and patient reported outcome measures. The study was planned as a double-blind, placebo-controlled, randomized, two-arm study. Participants in both treatment groups will be given exercise therapy in accordance with the early active mobilization protocol and appropriate splint will be given to be used while exercising.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being between the ages of 18-65
* Primary repair due to extensor tendon injury between Zones V-VIII
* Applying to the Hand Rehabilitation Policlinic at the end of the postoperative 1st week
Exclusion Criteria:
* Accompanying flexor tendon injury, fracture, vascular and / or nerve injury
* Active using of steroids or non-steroidal anti-inflammatory drugs
* Systemic infection or malignancy
* Pregnant or breastfeeding women
* Active wound infection
* Having a cognitive dysfunction
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in total active motion degrees
Timeframe: Pre-intervention, immediately after the intervention, eighth week
2
Grip strength
Timeframe: Eighth week
3
Change in visual analog scale (VAS) score
Timeframe: Pre-intervention, immediately after the intervention, eighth week
4
Change in metacarpophalangeal joint circumference
Timeframe: Pre-intervention, immediately after the intervention, eighth week